BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Juan‐Cheng Yang, Ning Chang, Deng‐Chyang Wu, Wei‐Chung Cheng, Wei‐Min Chung, Wei‐Chun Chang, Fu‐Ju Lei, Chung‐Jung Liu, I‐Chen Wu, Hsueh‐Chou Lai, Wen‐Lung Ma. Preclinical evaluation of exemestane as a novel chemotherapy for gastric cancerJournal of Cellular and Molecular Medicine 2019; 23(11): 7417 doi: 10.1111/jcmm.14605
2
Yung-Yu Hsieh, Shui-Yi Tung, Hung-Yu Pan, Chih-Wei Yen, Huang-Wei Xu, Yi-Fang Deng, Ying-Jhen Lin, Wan-Ting Hsu, Cheng-Shyong Wu, Chin Li. Upregulation of bone morphogenetic protein 1 is associated with poor prognosis of late-stage gastric Cancer patientsBMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4383-9
3
Aaron C. Tan, David L. Chan, Wasek Faisal, Nick Pavlakis. New drug developments in metastatic gastric cancerTherapeutic Advances in Gastroenterology 2018; 11: 175628481880807 doi: 10.1177/1756284818808072
4
Ewa Marcinkowska, Elżbieta Gocek. Resistance to Tyrosine Kinase InhibitorsResistance to Targeted Anti-Cancer Therapeutics 2016; : 1 doi: 10.1007/978-3-319-46091-8_1
5
L Liang, J-Y Fang, J Xu. Gastric cancer and gene copy number variation: emerging cancer drivers for targeted therapyOncogene 2016; 35(12): 1475 doi: 10.1038/onc.2015.209
6
Jie Sun, Junjie Piao, Nan Li, Yang Yang, Ki‐Yeol Kim, Zhenhua Lin. Valproic acid targets HDAC1/2 and HDAC1/PTEN/Akt signalling to inhibit cell proliferation via the induction of autophagy in gastric cancerThe FEBS Journal 2019;  doi: 10.1111/febs.15122
7
Lucas Faria Abrahao-Machado, Cristovam Scapulatempo-Neto. HER2 testing in gastric cancer: An updateWorld Journal of Gastroenterology 2016; 22(19): 4619-4625 doi: 10.3748/wjg.v22.i19.4619
8
Marta Smolińska, Dariusz Grzanka, Paulina Antosik, Anna Kasperska, Izabela Neska-Długosz, Jakub Jóźwicki, Anna Klimaszewska-Wiśniewska. HER2, NF-κB, and SATB1 Expression Patterns in Gastric Cancer and Their Correlation with Clinical and Pathological ParametersDisease Markers 2019; 2019: 1 doi: 10.1155/2019/6315936
9
Hanaa Amrani Hassani Joutei, Nabila Marchoudi, Wafaa Mahfoud, Ilham Sadaoui, Taoufiq Fechtali, Hakima Benomar. Characterization of PI3KCA and BRAF mutations in gastric adenocarcinoma: An approach to a personalized targeted therapy for Moroccan HER2 overexpressed patientsArab Journal of Gastroenterology 2018; 19(4): 155 doi: 10.1016/j.ajg.2018.08.001
10
Tasuku Matsuoka, Masakazu Yashiro. Biomarkers of gastric cancer: Current topics and future perspectiveWorld Journal of Gastroenterology 2018; 24(26): 2818-2832 doi: 10.3748/wjg.v24.i26.2818
11
Georgios D Lianos, Alberto Mangano, William C Cho, Dimitrios H Roukos. From standard to new genome-based therapy of gastric cancerExpert Review of Gastroenterology & Hepatology 2015; 9(8): 1023 doi: 10.1586/17474124.2015.1060856
12
Carmen S. M. Yong, Janelle Sharkey, Belinda Duscio, Ben Venville, Wei-Zen Wei, Richard F. Jones, Clare Y. Slaney, Gisela Mir Arnau, Anthony T. Papenfuss, Jan Schröder, Phillip K. Darcy, Michael H. Kershaw, John P. Lydon. Embryonic Lethality in Homozygous Human Her-2 Transgenic Mice Due to Disruption of the Pds5b GenePLOS ONE 2015; 10(9): e0136817 doi: 10.1371/journal.pone.0136817
13
Yajun Zhang, Lingfei Wang, Xiaodan Chong, Xiaojie Yu, Yanchun Meng, Jian Dong, Chao Wang, Huajing Wang, Yang Yang, Tian Xia, Jian Zhao, Bohua Li. A bispecific anti-ErbB2 antibody potently induces ErbB2 internalization and suppresses ErbB2-overexpressing tumor growthBiochemical and Biophysical Research Communications 2016; 477(4): 755 doi: 10.1016/j.bbrc.2016.06.131
14
Yukio Nagasaki. Design and application of redox polymers for nanomedicinePolymer Journal 2018; 50(9): 821 doi: 10.1038/s41428-018-0054-6
15
Zhaohui Jin, Harry H. Yoon. Antiangiogenic Therapy in Gastroesophageal CancerHematology/Oncology Clinics of North America 2017; 31(3): 499 doi: 10.1016/j.hoc.2017.01.008
16
Yunyun Pan, Zhengyang Yang, Yuping Xu, Zhicheng Bai, Donghui Pan, Runlin Yang, Lizhen Wang, Wenxian Guan, Min Yang. Targeting HER2-positive gastric cancer with a novel 18F-labeled ZHER2:342 probeRSC Advances 2019; 9(19): 10990 doi: 10.1039/C8RA10271F
17
Yuko T. Sato, Kaori Umezaki, Shinichi Sawada, Sada-atsu Mukai, Yoshihiro Sasaki, Naozumi Harada, Hiroshi Shiku, Kazunari Akiyoshi. Engineering hybrid exosomes by membrane fusion with liposomesScientific Reports 2016; 6(1) doi: 10.1038/srep21933
18
Sumi Yun, Jiwon Koh, Soo Kyung Nam, Jung Ok Park, Sung Mi Lee, Kyoungyul Lee, Kyu Sang Lee, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Gheeyoung Choe, Woo Ho Kim, Hye Seung Lee. Clinical significance of overexpression of NRG1 and its receptors, HER3 and HER4, in gastric cancer patientsGastric Cancer 2018; 21(2): 225 doi: 10.1007/s10120-017-0732-7
19
Yang-Kun Wang, Su-Nan Wang, Ying-Ying Li, Gong-Ping Wang, Tian Yun, Chao-Ya Zhu, Bin-Feng Yang, Cong-Yang Li, Bo Jiang, Mei-Ling Zhu. Methods and significance of the combined detection of HER2 gene amplification and chemosensitivity in gastric cancerCancer Biomarkers 2018; 21(2): 439 doi: 10.3233/CBM-170671